• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Drug Sensitivity and Resistance Mechanism in Aspergillus Section Strains from Japan.日本曲霉属菌株的药物敏感性及耐药机制
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.02583-16. Print 2017 Aug.
2
Cryptic species and azole resistance in the Aspergillus niger complex.黑曲霉复合体中的隐秘种和唑类耐药性。
Antimicrob Agents Chemother. 2011 Oct;55(10):4802-9. doi: 10.1128/AAC.00304-11. Epub 2011 Jul 18.
3
Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.临床和环境来源的黑曲霉群分离株的物种分布及体外唑类药物敏感性
J Clin Microbiol. 2016 Sep;54(9):2365-72. doi: 10.1128/JCM.01075-16. Epub 2016 Jul 13.
4
New Insights into the Cyp51 Contribution to Azole Resistance in Section .第 节中 Cyp51 对唑类药物耐药性贡献的新见解
Antimicrob Agents Chemother. 2019 Jun 24;63(7). doi: 10.1128/AAC.00543-19. Print 2019 Jul.
5
In Vitro Activities of Five Antifungal Drugs Against Opportunistic Agents of Aspergillus Nigri Complex.五种抗真菌药物对黑曲霉复合群机会性致病病原体的体外活性
Mycopathologia. 2016 Apr;181(3-4):235-40. doi: 10.1007/s11046-015-9968-0. Epub 2015 Nov 28.
6
First determination of azole resistance in Aspergillus fumigatus strains carrying the TR34/L98H mutations in Turkey.在土耳其首次测定携带TR34/L98H突变的烟曲霉菌株对唑类药物的耐药性。
J Infect Chemother. 2015 Aug;21(8):581-6. doi: 10.1016/j.jiac.2015.04.012. Epub 2015 May 14.
7
Aspergillus welwitschiae; an otomycosis predominant agent, new epidemiological and antifungal susceptibility data from Iran.韦氏曲霉;一种主要引起耳真菌病的病原体,来自伊朗的新流行病学和抗真菌药敏数据。
Microb Pathog. 2023 Aug;181:106180. doi: 10.1016/j.micpath.2023.106180. Epub 2023 May 29.
8
Prospective survey of Aspergillus species isolated from clinical specimens and their antifungal susceptibility: A five-year single-center study in Japan.从临床标本中分离的曲霉菌属及其抗真菌药敏性的前瞻性调查:日本五年单中心研究。
J Infect Chemother. 2020 Feb;26(2):321-323. doi: 10.1016/j.jiac.2019.09.002. Epub 2019 Sep 27.
9
Species distribution and antifungal susceptibility of clinical Aspergillus isolates: A multicentre study in Taiwan, 2016-2020.2016-2020 年台湾地区临床曲霉属分离株的种分布及抗真菌药敏性:一项多中心研究。
Mycoses. 2023 Aug;66(8):711-722. doi: 10.1111/myc.13593. Epub 2023 Apr 26.
10
High Prevalence of Azole-Resistant Aspergillus fumigatus Among Iranian Cystic Fibrosis Patients: Should We Be Concerned?伊朗囊性纤维化患者中烟曲霉对唑类药物耐药率高:我们是否应该担忧?
Mycoses. 2024 Sep;67(9):e13791. doi: 10.1111/myc.13791.

引用本文的文献

1
Aspergillus latus: A cryptic causative agent of aspergillosis emerging in Japan.宽曲霉:日本出现的一种曲霉病隐匿致病原。
Med Mycol. 2025 Jun 5;63(6). doi: 10.1093/mmy/myaf052.
2
Antifungal Resistance in Non-fumigatus Aspergillus Species.非烟曲霉属真菌中的抗真菌耐药性
Mycoses. 2025 Apr;68(4):e70051. doi: 10.1111/myc.70051.
3
Molecular Identification of Species, Antifungal Susceptibility, and Phenotypic Identification of Azole-Resistant Mutations in Cyp51A Gene Isolated from Xinjiang.新疆分离株的菌种分子鉴定、抗真菌药敏性及Cyp51A基因唑类耐药突变的表型鉴定
Infect Drug Resist. 2025 Apr 2;18:1699-1711. doi: 10.2147/IDR.S496489. eCollection 2025.
4
Pathogenic Aspergillus spp. and Candida spp. in coastal waters from southern Brazil: an one health approach.巴西南部沿海水域中的致病性曲霉菌属和念珠菌属:一种一体化健康方法。
Braz J Microbiol. 2025 Mar;56(1):179-189. doi: 10.1007/s42770-024-01604-7. Epub 2025 Jan 10.
5
Superficial abdominal surgical site infection caused by Aspergillus welwitschiae: a case report.由粗球腔菌引起的表浅性腹部外科手术部位感染:一例报告。
BMC Infect Dis. 2024 Sep 17;24(1):990. doi: 10.1186/s12879-024-09919-4.
6
Chronic pulmonary aspergillosis: comprehensive insights into epidemiology, treatment, and unresolved challenges.慢性肺曲霉病:关于流行病学、治疗及未解决挑战的全面见解
Ther Adv Infect Dis. 2024 Jun 18;11:20499361241253751. doi: 10.1177/20499361241253751. eCollection 2024 Jan-Dec.
7
Pathogenic Aspergillus Strains Identification and Antifungal Susceptibility Analysis of 452 Cases with Otomycosis in Jingzhou, China.中国荆州 452 例耳真菌病患者的致病曲霉菌株鉴定及抗真菌药敏分析。
Mycopathologia. 2024 Apr 5;189(2):30. doi: 10.1007/s11046-024-00836-3.
8
cyp51A mutations, protein modeling, and efflux pump gene expression reveals multifactorial complexity towards understanding Aspergillus section Nigri azole resistance mechanism.环细胞色素 P45051A 突变、蛋白质建模和外排泵基因表达揭示了理解黑曲霉属唑类耐药机制的多因素复杂性。
Sci Rep. 2024 Mar 14;14(1):6156. doi: 10.1038/s41598-024-55237-9.
9
Drug-Resistant spp.: A Literature Review of Its Resistance Mechanisms and Its Prevalence in Europe.耐药菌:欧洲耐药机制及其流行情况的文献综述
Pathogens. 2023 Oct 31;12(11):1305. doi: 10.3390/pathogens12111305.
10
Aspergillosis in a colony of Humboldt penguins (Spheniscus humboldti) in a french zoological park: evaluation of environmental exposure.法属动物园洪堡企鹅(Spheniscus humboldti)群体中的曲霉菌病:环境暴露评估。
Vet Res Commun. 2024 Feb;48(1):437-448. doi: 10.1007/s11259-023-10220-z. Epub 2023 Oct 11.

本文引用的文献

1
Epidemiological and Genomic Landscape of Azole Resistance Mechanisms in Fungi.真菌中唑类耐药机制的流行病学和基因组概况
Front Microbiol. 2016 Sep 21;7:1382. doi: 10.3389/fmicb.2016.01382. eCollection 2016.
2
Species Distribution and In Vitro Azole Susceptibility of Aspergillus Section Nigri Isolates from Clinical and Environmental Settings.临床和环境来源的黑曲霉群分离株的物种分布及体外唑类药物敏感性
J Clin Microbiol. 2016 Sep;54(9):2365-72. doi: 10.1128/JCM.01075-16. Epub 2016 Jul 13.
3
Clinical characteristics of patients with Aspergillus species isolation from respiratory samples: Comparison of chronic pulmonary aspergillosis and colonization.从呼吸道样本中分离出曲霉菌属的患者的临床特征:慢性肺曲霉病与定植的比较。
Respir Investig. 2016 Mar;54(2):92-7. doi: 10.1016/j.resinv.2015.08.007. Epub 2015 Oct 20.
4
Aspergillus tubingensis and Aspergillus niger as the dominant black Aspergillus, use of simple PCR-RFLP for preliminary differentiation.土曲霉和黑曲霉为主要的黑色曲霉菌,使用简单的 PCR-RFLP 进行初步区分。
J Mycol Med. 2016 Mar;26(1):9-16. doi: 10.1016/j.mycmed.2015.12.004. Epub 2016 Feb 3.
5
Aspergillus tubingensis: a major filamentous fungus found in the airways of patients with lung disease.土曲霉:一种在肺部疾病患者气道中发现的主要丝状真菌。
Med Mycol. 2016 Jul 1;54(5):459-70. doi: 10.1093/mmy/myv118. Epub 2016 Jan 14.
6
Identification and susceptibility of Aspergillus section nigri in china: prevalence of species and paradoxical growth in response to echinocandins.中国黑曲霉群的鉴定与易感性:菌种流行情况及对棘白菌素的矛盾生长反应
J Clin Microbiol. 2015 Feb;53(2):702-5. doi: 10.1128/JCM.03233-14. Epub 2014 Dec 10.
7
Antifungal susceptibility of Aspergillus fumigatus clinical isolates collected from various areas in Japan.从日本不同地区收集的烟曲霉临床分离株的抗真菌药敏性。
J Infect Chemother. 2014 May;20(5):336-8. doi: 10.1016/j.jiac.2014.01.003.
8
NikA/TcsC histidine kinase is involved in conidiation, hyphal morphology, and responses to osmotic stress and antifungal chemicals in Aspergillus fumigatus.NikA/TcsC组氨酸激酶参与烟曲霉的分生孢子形成、菌丝形态以及对渗透胁迫和抗真菌化学物质的应答。
PLoS One. 2013 Dec 2;8(12):e80881. doi: 10.1371/journal.pone.0080881. eCollection 2013.
9
Aspergillus luchuensis, an industrially important black Aspergillus in East Asia.卢氏被毛孢,东亚地区一种具有重要工业用途的黑色被毛孢。
PLoS One. 2013 May 28;8(5):e63769. doi: 10.1371/journal.pone.0063769. Print 2013.
10
High-level expression of cyp51B in azole-resistant clinical Aspergillus fumigatus isolates.唑类耐药临床烟曲霉分离株中 CYP51B 的高水平表达。
J Antimicrob Chemother. 2013 Mar;68(3):512-4. doi: 10.1093/jac/dks451. Epub 2012 Dec 2.

日本曲霉属菌株的药物敏感性及耐药机制

Drug Sensitivity and Resistance Mechanism in Aspergillus Section Strains from Japan.

作者信息

Hashimoto Aki, Hagiwara Daisuke, Watanabe Akira, Yahiro Maki, Yikelamu Alimu, Yaguchi Takashi, Kamei Katsuhiko

机构信息

Division of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan.

Division of Clinical Research, Medical Mycology Research Center, Chiba University, Chiba, Japan

出版信息

Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.02583-16. Print 2017 Aug.

DOI:10.1128/AAC.02583-16
PMID:28607016
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5527657/
Abstract

and its related species, known as section , are ubiquitously distributed across the globe and are often isolated from clinical specimens. In Japan, section is second most often isolated from clinical specimens following We determined the species of section isolated in Japan by DNA sequencing of partial β-tubulin genes and investigated drug susceptibility by the CLSI M38-A2 method. The collection contained 20 , 59 , and 39 strains. Drug susceptibility testing revealed 30 to 55% of , 6.8 to 18.6% of , and 79.5 to 89.7% of isolates to be less susceptible (so-called resistant) to itraconazole (ITC) and/or voriconazole (VRC) according to the epidemiologic cutoff values (ECVs) proposed for previously. MIC distributions of ITC or VRC showed no remarkable differences between clinical and environmental isolates. When the sequences were compared between susceptible and resistant strains, 18 amino acid mutations were specific for resistant isolates of and ; however, none of them were confirmed to be associated with azole resistance. Three nonrelated isolates possessed a partial deletion in , likely attributable to being more susceptible to azoles than other isolates. One of five ITC-resistant isolates showed higher expression of than did susceptible strains. Our results show that point mutations may have no association with azole resistance but that in some cases the overexpression of may lead to the azole resistance in these species.

摘要

及其相关菌种,即 组,在全球广泛分布,且常常从临床标本中分离得到。在日本, 组是继 之后第二常从临床标本中分离出的菌种。我们通过对部分β-微管蛋白基因进行DNA测序确定了在日本分离出的 组菌种,并采用CLSI M38-A2方法研究了药物敏感性。该菌株集合包含20株 、59株 和39株 菌株。药敏试验显示,根据之前针对 提出的流行病学临界值(ECV),30%至55%的 、6.8%至18.6%的 以及79.5%至89.7%的 分离株对伊曲康唑(ITC)和/或伏立康唑(VRC)敏感性较低(即所谓耐药)。ITC或VRC的MIC分布在临床分离株和环境分离株之间未显示出显著差异。当比较敏感和耐药菌株之间的 序列时,18个氨基酸突变是 和 耐药分离株所特有的;然而,它们均未被证实与唑类耐药相关。三株不相关的 分离株在 中存在部分缺失,这可能归因于它们比其他分离株对唑类更敏感。五株ITC耐药的 分离株中有一株显示出比敏感菌株更高的 表达。我们的结果表明, 点突变可能与唑类耐药无关,但在某些情况下, 的过表达可能导致这些菌种出现唑类耐药。